API's corporate philosophy is "Making People Healthy with Honeybees".Based on this mantra, we have continued working for over 100 years since our founding in 1907.
In today's super-aging society, the demand for medical care, nursing care and welfare services is on the rise. People want to grow old healthily, and it is also our wish to help make people healthier. The supplement industry is situated between the medicine and food industries, and the positive effects of supplements are well known. Awareness of supplements throughout society continues to grow.
As an OEM manufacturer, we strive to respond to all of our customers' demands. We aim to provide total support from marketing to material procurement, planning, development, technology, and manufacturing as well as assured quality.
Since our founding we have continuously taken on new challenges, moving from the apiculture industry into the contract manufacturing of health foods. In 2004 we advanced into the pharmaceutical industry by building a new factory for the contract manufacturing of drugs.
There are still many hurdles we must overcome, but we will continue to tackle new challenges without fear of change in order to keep meeting the needs of our customers.
In 2004, he founded and served as CEO of PAI Life Sciences Inc., a bioinformatics company with proprietary drug discovery technologies using artificial neural nets. Darrick also served as Chief Scientific Officer at a specialty pharmaceutical company focused on drug and device combinations, is a founding member of a company focused on immunotherapy in oncology, and a founding member of a device company working on inflammatory disorders. Darrick sits on the Scientific Advisory Boards of three local biotech companies and hosts a website for protein chemists. He has authored over 50 peer-reviewed papers and is inventor/co-inventor on more than 160 patent applications and issued patents.
Androgens are responsible for the growth spurt of adolescence and for the eventual termination of linear growth, which is brought about by fusion of the epiphyseal growth centers. In children, exogenous androgens accelerate linear growth rates but may cause a disproportionate advancement in bone maturation. Use over long periods may result in fusion of the epiphyseal growth centers and termination of growth process. Androgens have been reported to stimulate the production of red blood cells by enhancing the production of erythropoeitic stimulating factor. During exogenous administration of androgens,Â endogenous testosterone Â release is inhibited through feedback inhibition of pituitary luteinizing hormone (LH).